Sign in
4

Changes in Ownership

Whitehawk Therapeutics, Inc. Filed Acc 0000902664-22-004356

Director acquired 1,260,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Aghazadeh Behzad · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-09-22 Grant or award : show line 1 in the form +1,260,000 $12.50 $15,750,000 3,471,752 I
Loading xslF345X03/ownership.xml…